vs

Side-by-side financial comparison of Chord Energy Corp (CHRD) and Healthpeak Properties (DOC). Click either name above to swap in a different company.

Chord Energy Corp is the larger business by last-quarter revenue ($1.2B vs $719.4M, roughly 1.6× Healthpeak Properties). Healthpeak Properties runs the higher net margin — 73.2% vs 7.2%, a 66.0% gap on every dollar of revenue. On growth, Healthpeak Properties posted the faster year-over-year revenue change (3.1% vs -19.6%). Over the past eight quarters, Healthpeak Properties's revenue compounded faster (8.9% CAGR vs 3.8%).

Chord Energy Corporation is a company engaged in hydrocarbon exploration and hydraulic fracturing in the Williston Basin in North Dakota and Montana. It is organized in Delaware and headquartered in Houston, Texas, with an office in Williston, North Dakota. The company was formerly known as Oasis Petroleum.

Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.

CHRD vs DOC — Head-to-Head

Bigger by revenue
CHRD
CHRD
1.6× larger
CHRD
$1.2B
$719.4M
DOC
Growing faster (revenue YoY)
DOC
DOC
+22.7% gap
DOC
3.1%
-19.6%
CHRD
Higher net margin
DOC
DOC
66.0% more per $
DOC
73.2%
7.2%
CHRD
Faster 2-yr revenue CAGR
DOC
DOC
Annualised
DOC
8.9%
3.8%
CHRD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CHRD
CHRD
DOC
DOC
Revenue
$1.2B
$719.4M
Net Profit
$84.4M
$114.0M
Gross Margin
Operating Margin
7.9%
17.4%
Net Margin
7.2%
73.2%
Revenue YoY
-19.6%
3.1%
Net Profit YoY
-59.9%
2406.4%
EPS (diluted)
$1.59
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHRD
CHRD
DOC
DOC
Q4 25
$1.2B
$719.4M
Q3 25
$1.3B
$705.9M
Q2 25
$1.2B
$694.3M
Q1 25
$1.2B
$702.9M
Q4 24
$1.5B
$698.0M
Q3 24
$1.5B
$700.4M
Q2 24
$1.3B
$695.5M
Q1 24
$1.1B
$606.6M
Net Profit
CHRD
CHRD
DOC
DOC
Q4 25
$84.4M
$114.0M
Q3 25
$130.1M
$-117.1M
Q2 25
$-389.9M
$31.7M
Q1 25
$219.8M
$42.8M
Q4 24
$210.6M
$4.5M
Q3 24
$225.3M
$85.9M
Q2 24
$213.4M
$146.0M
Q1 24
$199.4M
$6.7M
Gross Margin
CHRD
CHRD
DOC
DOC
Q4 25
Q3 25
74.0%
58.6%
Q2 25
60.2%
Q1 25
61.1%
Q4 24
60.3%
Q3 24
77.3%
60.0%
Q2 24
60.6%
Q1 24
59.8%
Operating Margin
CHRD
CHRD
DOC
DOC
Q4 25
7.9%
17.4%
Q3 25
13.0%
9.2%
Q2 25
-34.2%
5.7%
Q1 25
27.8%
7.7%
Q4 24
18.2%
-2.2%
Q3 24
18.8%
14.1%
Q2 24
22.9%
22.3%
Q1 24
25.1%
3.7%
Net Margin
CHRD
CHRD
DOC
DOC
Q4 25
7.2%
73.2%
Q3 25
9.9%
-16.6%
Q2 25
-33.0%
4.6%
Q1 25
18.1%
6.1%
Q4 24
14.5%
0.7%
Q3 24
15.5%
12.3%
Q2 24
16.9%
21.0%
Q1 24
18.4%
1.1%
EPS (diluted)
CHRD
CHRD
DOC
DOC
Q4 25
$1.59
$0.16
Q3 25
$2.26
$-0.17
Q2 25
$-6.77
$0.05
Q1 25
$3.66
$0.06
Q4 24
$3.53
$0.02
Q3 24
$3.59
$0.12
Q2 24
$4.25
$0.21
Q1 24
$4.65
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHRD
CHRD
DOC
DOC
Cash + ST InvestmentsLiquidity on hand
$189.5M
$467.5M
Total DebtLower is stronger
$1.5B
$9.8B
Stockholders' EquityBook value
$8.1B
$7.5B
Total Assets
$13.1B
$20.3B
Debt / EquityLower = less leverage
0.18×
1.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHRD
CHRD
DOC
DOC
Q4 25
$189.5M
$467.5M
Q3 25
$629.2M
$91.0M
Q2 25
$40.5M
$89.4M
Q1 25
$35.8M
$70.6M
Q4 24
$37.0M
$119.8M
Q3 24
$52.0M
$180.4M
Q2 24
$197.4M
$106.9M
Q1 24
$296.4M
$101.8M
Total Debt
CHRD
CHRD
DOC
DOC
Q4 25
$1.5B
$9.8B
Q3 25
$1.5B
$9.1B
Q2 25
$918.9M
$9.0B
Q1 25
$798.8M
$8.9B
Q4 24
$842.6M
$8.7B
Q3 24
$867.2M
$8.6B
Q2 24
$1.0B
$8.6B
Q1 24
$396.3M
$8.8B
Stockholders' Equity
CHRD
CHRD
DOC
DOC
Q4 25
$8.1B
$7.5B
Q3 25
$8.1B
$7.6B
Q2 25
$8.1B
$7.9B
Q1 25
$8.6B
$8.2B
Q4 24
$8.7B
$8.4B
Q3 24
$8.8B
$8.6B
Q2 24
$8.8B
$8.8B
Q1 24
$5.1B
$8.9B
Total Assets
CHRD
CHRD
DOC
DOC
Q4 25
$13.1B
$20.3B
Q3 25
$13.1B
$19.6B
Q2 25
$12.5B
$19.8B
Q1 25
$13.1B
$19.8B
Q4 24
$13.0B
$19.9B
Q3 24
$13.0B
$20.0B
Q2 24
$13.1B
$20.2B
Q1 24
$7.0B
$20.5B
Debt / Equity
CHRD
CHRD
DOC
DOC
Q4 25
0.18×
1.31×
Q3 25
0.18×
1.20×
Q2 25
0.11×
1.14×
Q1 25
0.09×
1.08×
Q4 24
0.10×
1.04×
Q3 24
0.10×
1.00×
Q2 24
0.12×
0.98×
Q1 24
0.08×
0.99×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHRD
CHRD
DOC
DOC
Operating Cash FlowLast quarter
$405.0M
$1.3B
Free Cash FlowOCF − Capex
$357.0M
FCF MarginFCF / Revenue
49.6%
Capex IntensityCapex / Revenue
124.4%
Cash ConversionOCF / Net Profit
4.80×
10.99×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHRD
CHRD
DOC
DOC
Q4 25
$405.0M
$1.3B
Q3 25
$559.0M
$315.0M
Q2 25
$419.8M
$363.5M
Q1 25
$656.9M
$279.4M
Q4 24
$566.5M
$1.1B
Q3 24
$663.2M
$318.2M
Q2 24
$460.9M
$316.2M
Q1 24
$406.7M
$152.6M
Free Cash Flow
CHRD
CHRD
DOC
DOC
Q4 25
$357.0M
Q3 25
Q2 25
Q1 25
Q4 24
$333.7M
Q3 24
Q2 24
Q1 24
FCF Margin
CHRD
CHRD
DOC
DOC
Q4 25
49.6%
Q3 25
Q2 25
Q1 25
Q4 24
47.8%
Q3 24
Q2 24
Q1 24
Capex Intensity
CHRD
CHRD
DOC
DOC
Q4 25
124.4%
Q3 25
Q2 25
Q1 25
Q4 24
105.6%
Q3 24
Q2 24
Q1 24
Cash Conversion
CHRD
CHRD
DOC
DOC
Q4 25
4.80×
10.99×
Q3 25
4.30×
Q2 25
11.48×
Q1 25
2.99×
6.52×
Q4 24
2.69×
235.43×
Q3 24
2.94×
3.71×
Q2 24
2.16×
2.17×
Q1 24
2.04×
22.85×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CHRD
CHRD

Oil Production$801.0M68%
Purchased Oil Sales$285.8M24%
Natural Gas And Natural Gas Liquid Services$75.6M6%
Purchased Gas Sales$7.0M1%

DOC
DOC

Segment breakdown not available.

Related Comparisons